SURVEY – Anticipation of regulatory needs for nanotechnology-enabled health products.
BACK TO NEWSROOM
Communications Disseminations Generic 13.07.2020

SURVEY – Anticipation of regulatory needs for nanotechnology-enabled health products.

Launched in December 2017, H2020 project REFINE aims to develop a regulatory science framework for nanotechnology-enabled health products. Recently released REFINE’s White Paper summarises main regulatory challenges in the field and provides information on relevant legislative/regulatory frameworks and involved organisations.

The REFINE White Paper and related scientific publication “Launching stakeholder discussions on identified regulatory needs for nanotechnology-enabled health products” call for a discussion on identified challenges among the involved communities, including regulators, industry and academia. In order to better understand the needs and perspectives of different communities a short questionnaire is available HERE. The feedback should help to develop an improved version of the White Paper